A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.

A diagnosis of uveal melanoma marks the beginning of a long-term relationship with your medical team. While the focus starts ...

Patients with severe melanoma who received the treatment were 49% less likely to die or have their cancer return, ...

A paper published in Biology Methods and Protocols, indicates that a new computational method may help researchers identify ...

A genetically modified version of the virus behind cold sores might one day help people who’ve run out of other options. A modified herpesvirus combined with an immunotherapy drug shrank or eliminated ...

A large multinational clinical trial has found that giving health care providers access to European Organization for Research ...